The cholesterol ester transfer protein (CETP) facilitates the transfer of HDL cholesterol esters from plasma to the liver. Transgenic mice expressing human CETP, controlled by its natural flanking region, increase expression of this gene in response to hypercholesterolemia. We established a CETP promoter-luciferase reporter assay in differentiated 3T3-L1 adipocytes to map the sterol upregulatory element. Promoter mutagenesis suggested that a direct repeat of a nuclear receptor binding sequence separated by 4 nucleotides (DR4 element, –384 to –399) was responsible for this activity. Using mice carrying normal or mutated promoter sequences, we confirmed the importance of this element for gene induction by dietary sterol. A gel retardation complex containing LXR/RXR was identified using the CETP DR4 element and adipocyte nuclear extracts. Both LXRα/RXRα and LXRβ/RXRα transactivated the CETP promoter via its DR4 element in a sterol-responsive fashion. Thus, the positive sterol response of the CETP gene is mediated by a nuclear receptor binding site that is activated by LXRs. That Cyp7a, the rate-limiting enzyme for conversion of cholesterol into bile acids in the liver, is also regulated by LXRα suggests that this class of nuclear receptor coordinates the regulation of HDL cholesterol ester catabolism and bile acid synthesis in the liver.
Yi Luo, Alan R. Tall
Title and authors | Publication | Year |
---|---|---|
Future therapeutic perspectives in nonalcoholic fatty liver disease: a focus on nuclear receptors, a promising therapeutic target
Stan SI, Biciuşcă V, Clenciu D, Mitrea A, Boldeanu MV, Durand P, Dănoiu S |
Medicine and pharmacy reports | 2024 |
Damaging mutations in liver X receptor-α are hepatotoxic and implicate cholesterol sensing in liver health.
Lockhart SM, Muso M, Zvetkova I, Lam BYH, Ferrari A, Schoenmakers E, Duckett K, Leslie J, Collins A, Romartínez-Alonso B, Tadross JA, Jia R, Gardner EJ, Kentistou K, Zhao Y, Day F, Mörseburg A, Rainbow K, Rimmington D, Mastantuoni M, Harrison J, Nus M, Guma'a K, Sherratt-Mayhew S, Jiang X, Smith KR, Paul DS, Jenkins B, Koulman A, Pietzner M, Langenberg C, Wareham N, Yeo GS, Chatterjee K, Schwabe J, Oakley F, Mann DA, Tontonoz P, Coll AP, Ong K, Perry JRB, O'Rahilly S |
Nature metabolism | 2024 |
The Composition of the HDL Particle and Its Capacity to Remove Cellular Cholesterol Are Associated with a Reduced Risk of Developing Active Inflammatory Rheumatoid Arthritis.
Giacaglia MB, Felix VP, Santana MFM, Amendola LS, Lerner PG, Fernandes SDE, Camacho CP, Passarelli M |
International journal of molecular sciences | 2024 |
Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases.
Griffett K, Burris TP |
Frontiers in Medicine | 2023 |
Structure-based mechanism and inhibition of cholesteryl ester transfer protein.
Xue H, Zhang M, Liu J, Wang J, Ren G |
Current Atherosclerosis Reports | 2023 |
Targeting Liver X Receptors for the Treatment of Non-Alcoholic Fatty Liver Disease
Kim H, Park C, Kim TH |
Cells | 2023 |
The roles of nuclear receptors in cholesterol metabolism and reverse cholesterol transport in nonalcoholic fatty liver disease
Li Z, Zheng D, Zhang T, Ruan S, Li N, Yu Y, Peng Y, Wang D |
Hepatology Communications | 2023 |
Expressing the Human Cholesteryl Ester Transfer Protein Minigene Improves Diet-Induced Fatty Liver and Insulin Resistance in Female Mice.
Zhu L, An J, Chinnarasu S, Luu T, Pettway YD, Fahey K, Litts B, Kim HH, Flynn CR, Linton MF, Stafford JM |
Frontiers in physiology | 2022 |
Clinical diversity and molecular mechanism of VPS35L-associated Ritscher-Schinzel syndrome.
Otsuji S, Nishio Y, Tsujita M, Rio M, Huber C, Antón-Plágaro C, Mizuno S, Kawano Y, Miyatake S, Simon M, van Binsbergen E, van Jaarsveld RH, Matsumoto N, Cormier-Daire V, J Cullen P, Saitoh S, Kato K |
Journal of medical genetics | 2022 |
Liver X receptors and liver physiology
L Russo-Savage, IG Schulman |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2021 |
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang |
2020 | |
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang |
2020 | |
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang |
2020 | |
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang |
2020 | |
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang |
2020 | |
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang |
2020 | |
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang |
2020 | |
Hydrogen sulfide accumulates LDL receptor precursor via downregulating PCSK9 in HepG2 cells
Y Huang, K Ning, WW Li, G Lin, CL Hou, MJ Wang, YC Zhu |
American journal of physiology. Cell physiology | 2020 |
Identification of a hormone response element that mediates suppression of APOF by LXR and PPARα agonists
Y Liu, L Izem, RE Morton |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2020 |
Mammalian Sterols: Novel Biological Roles of Cholesterol Synthesis Intermediates, Oxysterols and Bile Acids
D Rozman, R Gebhardt |
2020 | |
Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment
A Chimento, I Casaburi, P Avena, F Trotta, AD Luca, V Rago, V Pezzi, R Sirianni |
Frontiers in Endocrinology | 2019 |
Hepatic triglyceride content does not affect circulating CETP: lessons from a liraglutide intervention trial and a population-based cohort.
van Eyk HJ, Blauw LL, Bizino MB, Wang Y, van Dijk KW, de Mutsert R, Smit JWA, Lamb HJ, Jazet IM, Rensen PCN |
Scientific Reports | 2019 |
Activation of liver X receptor promotes fatty acid synthesis in goat mammary epithelial cells via modulation of SREBP1 expression
HF Xu, J Luo, XY Zhang, J Li, M Bionaz |
Journal of Dairy Science | 2019 |
Niacin regulates apolipoprotein M expression via liver X receptor‑α
L Yang, T Li, S Zhao, S Zhang |
Molecular medicine reports | 2019 |
Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR
V Hiebl, A Ladurner, S Latkolik, VM Dirsch |
Biotechnology Advances | 2018 |
Liver X receptors in lipid signalling and membrane homeostasis
B Wang, P Tontonoz |
Nature Reviews Endocrinology | 2018 |
Lipopolysaccharide Lowers Cholesteryl Ester Transfer Protein by Activating F4/80 + Clec4f + Vsig4 + Ly6C − Kupffer Cell Subsets
SJ van der Tuin, Z Li, JF Berbée, I Verkouter, LE Ringnalda, AE Neele, JB van Klinken, SS Rensen, J Fu, MP de Winther, AK Groen, PC Rensen, KW van Dijk, Y Wang |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2018 |
Cholesteryl ester transfer protein and its inhibitors
S Shrestha, BJ Wu, L Guiney, PJ Barter, KA Rye |
Journal of lipid research | 2018 |
Cholesterol Metabolism Is Enhanced in the Liver and Brain of Children With Citrin Deficiency
S Hirayama, H Nagasaka, A Honda, H Komatsu, T Kodama, A Inui, I Morioka, S Kaji, T Ueno, K Ihara, M Yagi, Z Kizaki, K Bessho, H Kondou, T Yorifuji, H Tsukahara, K Iijima, T Miida |
The Journal of clinical endocrinology and metabolism | 2018 |
Metabolic liver inflammation in obesity does not robustly decrease hepatic and circulating CETP
LL Blauw, Z Li, SS Rensen, JW Greve, A Verhoeven, RJ Derks, M Giera, Y Wang, PC Rensen |
Atherosclerosis | 2018 |
Targeting bile acids and lipotoxicity for NASH treatment: Chiang
JY Chiang |
Hepatology Communications | 2017 |
Liver X Receptor Gene Expression is Enhanced in Children with Obstructive Sleep Apnea-Hyperpnoea Syndrome and Cyclooxygenase-2 (COX-2) is Correlated with Severity of Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)
XH Ye, H Chen, Q Yu, QL Zhu |
Medical science monitor : international medical journal of experimental and clinical research | 2017 |
Liver X Receptor Gene Expression is Enhanced in Children with Obstructive Sleep Apnea-Hyperpnoea Syndrome and Cyclooxygenase-2 (COX-2) is Correlated with Severity of Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS).
Ye XH, Chen H, Yu Q, Zhu QL |
Medical science monitor : international medical journal of experimental and clinical research | 2017 |
Once and for all, LXRα and LXRβ are gatekeepers of the endocrine system
S Maqdasy, A Trousson, I Tauveron, DH Volle, S Baron, JM Lobaccaro |
Molecular Aspects of Medicine | 2016 |
Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils
TG Kirchgessner, P Sleph, J Ostrowski, J Lupisella, CS Ryan, X Liu, G Fernando, D Grimm, P Shipkova, R Zhang, R Garcia, J Zhu, A He, H Malone, R Martin, K Behnia, Z Wang, YC Barrett, RJ Garmise, L Yuan, J Zhang, MD Gandhi, P Wastall, T Li, S Du, L Salvador, R Mohan, GH Cantor, E Kick, J Lee, RJ Frost |
Cell Metabolism | 2016 |
Zinc alpha2 glycoprotein alleviates palmitic acid-induced intracellular lipid accumulation in hepatocytes
X Xiao, H Li, X Qi, Y Wang, C Xu, G Liu, G Wen, J Liu |
Molecular and Cellular Endocrinology | 2016 |
Arsenic trioxide suppresses liver X receptor β and enhances cholesteryl ester transfer protein expression without affecting the liver X receptor α in HepG2 cells
TJ Cheng, SW Lin, CW Chen, HR Guo, YJ Wang |
Chemico-Biological Interactions | 2016 |
Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association
A Shimada, H Kimura, K Oida, H Kanehara, Y Bando, S Sakamoto, T Wakasugi, T Saga, Y Ito, K Kamiyama, D Mikami, M Iwano, T Hirano, H Yoshida |
Lipids in Health and Disease | 2016 |
Serum CETP concentration is not associated with measures of body fat: The NEO study
LL Blauw, R Mutsert, HJ Lamb, A Roos, FR Rosendaal, JW Jukema, Y Wang, KW van Dijk, PC Rensen |
Atherosclerosis | 2016 |
Discovery of Highly Potent Liver X Receptor β Agonists
EK Kick, BB Busch, R Martin, WC Stevens, V Bollu, Y Xie, BC Boren, MC Nyman, MH Nanao, L Nguyen, A Plonowski, IG Schulman, G Yan, H Zhang, X Hou, MN Valente, R Narayanan, K Behnia, AD Rodrigues, B Brock, J Smalley, GH Cantor, J Lupisella, P Sleph, D Grimm, J Ostrowski, RR Wexler, T Kirchgessner, R Mohan |
ACS Medicinal Chemistry Letters | 2016 |
Liver X receptors at the intersection of lipid metabolism and atherogenesis
SD Lee, P Tontonoz |
Atherosclerosis | 2015 |
High-density lipoprotein synthesis and metabolism (Review)
L Zhou, C Li, L Gao, A Wang |
Molecular medicine reports | 2015 |
The potential of cholesteryl ester transfer protein as a therapeutic target
T Gautier, D Masson, L Lagrost |
Expert Opinion on Therapeutic Targets | 2015 |
Regulation of Hepatic Cholesteryl Ester Transfer Protein Expression and Reverse Cholesterol Transport by Inhibition of DNA Topoisomerase II
M Liu, Y Chen, L Zhang, Q Wang, X Ma, X Li, R Xiang, Y Zhu, S Qin, Y Yu, X Jiang, Y Duan, J Han |
The Journal of biological chemistry | 2015 |
Plasma cholesteryl ester transfer protein is predominantly derived from Kupffer cells: HEPATOLOGY, Vol. XX, No. X, 2015
Y Wang, S der Tuin, N Tjeerdema, AD van Dam, SS Rensen, T Hendrikx, JF Berbée, B Atanasovska, J Fu, M Hoekstra, S Bekkering, NP Riksen, WA Buurman, JW Greve, MH Hofker, R Shiri-Sverdlov, OC Meijer, JW Smit, LM Havekes, KW van Dijk, PC Rensen |
Hepatology | 2015 |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
Liver X receptors in lipid metabolism: opportunities for drug discovery
C Hong, P Tontonoz |
Nature Reviews Drug Discovery | 2014 |
Coordinated Actions of FXR and LXR in Metabolism: From Pathogenesis to Pharmacological Targets for Type 2 Diabetes
L Ding, S Pang, Y Sun, Y Tian, L Yu, N Dang |
International Journal of Endocrinology | 2014 |
Pharmacological Characterization of a Novel Liver X Receptor Agonist with Partial LXR α Activity and a Favorable Window in Nonhuman Primates
TG Kirchgessner, R Martin, P Sleph, D Grimm, X Liu, J Lupisella, J Smalley, R Narayanan, Y Xie, J Ostrowski, G H., R Mohan, E Kick |
The Journal of pharmacology and experimental therapeutics | 2014 |
Elevated CETP activity during acute phase of myocardial infarction is independently associated with endothelial dysfunction and adverse clinical outcome
LS Carvalho, VW Virginio, NB Panzoldo, VN Figueiredo, SN Santos, RG Modolo, JM Andrade, JC Silva, W Nadruz-Junior, EC de Faria, AC Sposito |
Atherosclerosis | 2014 |
The LXR–Idol Axis Differentially Regulates Plasma LDL Levels in Primates and Mice
C Hong, SM Marshall, AL McDaniel, M Graham, JD Layne, L Cai, E Scotti, R Boyadjian, J Kim, BT Chamberlain, RK Tangirala, ME Jung, L Fong, R Lee, SG Young, RE Temel, P Tontonoz |
Cell Metabolism | 2014 |
Macrophage-Independent Regulation of Reverse Cholesterol Transport by Liver X Receptors
SR Breevoort, J Angdisen, IG Schulman |
Arteriosclerosis, thrombosis, and vascular biology | 2014 |
Fibrates and fish oil, but not corn oil, up-regulate the expression of the cholesteryl ester transfer protein (CETP) gene
HF Raposo, PR Patrício, MC Simões, HC Oliveira |
The Journal of Nutritional Biochemistry | 2014 |
Liver X Receptor: A Cardinal Target for Atherosclerosis and Beyond
M Parikh, K Patel, S Soni, T Gandhi |
Journal of Atherosclerosis and Thrombosis | 2014 |
The Medicinal Chemistry of Liver X Receptor (LXR) Modulators
CM Tice, PB Noto, KY Fan, L Zhuang, DS Lala, SB Singh |
Journal of Medicinal Chemistry | 2014 |
Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice
T Gautier, W Haan, J Grober, D Ye, MJ Bahr, T Claudel, N Nijstad, TJ van Berkel, LM Havekes, MP Manns, SM Willems, PC Hogendoorn, L Lagrost, F Kuipers, MV Eck, PC Rensen, UJ Tietge |
Journal of lipid research | 2013 |
Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice[S]
T Gautier, W Haan, J Grober, D Ye, MJ Bahr, T Claudel, N Nijstad, TJ van Berkel, LM Havekes, MP Manns, SM Willems, PC Hogendoorn, L Lagrost, F Kuipers, MV Eck, PC Rensen, UJ Tietge |
Journal of lipid research | 2013 |
Genome-wide landscape of liver X receptor chromatin binding and gene regulation in human macrophages
P Pehkonen, L Welter-Stahl, J Diwo, J Ryynänen, A Wienecke-Baldacchino, S Heikkinen, E Treuter, KR Steffensen, C Carlberg |
BMC Genomics | 2012 |
Nuclear Receptors in Nonalcoholic Fatty Liver Disease
JA López-Velázquez, LD Carrillo-Córdova, NC Chávez-Tapia, M Uribe, N Méndez-Sánchez |
Journal of Lipids | 2012 |
The Effects of Jiang-Zhi-Ning and Its Main Components on Cholesterol Metabolism
J Chen, H Zhao, X Ma, X Han, L Luo, L Wang, J Han, B Liu, W Wang |
Evidence-based complementary and alternative medicine : eCAM | 2012 |
Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR
AC Calkin, P Tontonoz |
Nature Reviews Molecular Cell Biology | 2012 |
The role of nuclear receptors in the kidney in obesity and metabolic syndrome
C Tovar-Palacio, N Torres, A Diaz-Villaseñor, AR Tovar |
Genes & Nutrition | 2012 |
Identification of Biological Markers of Liver X Receptor (LXR) Activation at the Cell Surface of Human Monocytes
C Rébé, R Filomenko, M Raveneau, A Chevriaux, M Ishibashi, L Lagrost, JL Junien, P Gambert, D Masson |
PloS one | 2012 |
Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice
Z Li, Y Wang, RJ van der Sluis, JW van der Hoorn, HM Princen, MV Eck, TJ van Berkel, PC Rensen, M Hoekstra |
Biochemical Pharmacology | 2012 |
Cholesterol and male fertility: What about orphans and adopted?
S Maqdasy, M Baptissart, A Vega, S Baron, JM Lobaccaro, DH Volle |
Molecular and Cellular Endocrinology | 2012 |
Atherosclerosis: lessons from LXR and the intestine
B Bonamassa, A Moschetta |
Trends in Endocrinology & Metabolism | 2012 |
SREBP: a novel therapeutic target
X Xiao, BL Song |
Acta Biochimica et Biophysica Sinica | 2012 |
Identification of Biological Markers of Liver X Receptor (LXR) Activation at the Cell Surface of Human Monocytes
C Rébé, R Filomenko, M Raveneau, A Chevriaux, M Ishibashi, L Lagrost, JL Junien, P Gambert, D Masson, CM Maya-Monteiro |
PloS one | 2012 |
Nuclear Hormone Receptors Enable Macrophages and Dendritic Cells to Sense Their Lipid Environment and Shape Their Immune Response
L Nagy, A Szanto, I Szatmari, L Széles |
Physiological reviews | 2012 |
Orphan Nuclear Receptors and the Regulation of Nutrient Metabolism: Understanding Obesity
MA Pearen, GE Muscat |
Physiology (Bethesda, Md.) | 2012 |
Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases plasma CETP and increases apolipoprotein AI levels without improving the cholesterol efflux properties of HDL
Y Wang, M Snel, JT Jonker, S Hammer, HJ Lamb, A Roos, AE Meinders, H Pijl, JA Romijn, JW Smit, IM Jazet, PC Rensen |
Diabetes care | 2011 |
Cholesteryl ester transfer protein: The controversial relation to atherosclerosis and emerging new biological roles
HC Oliveira, EC de Faria |
IUBMB Life | 2011 |
Plasma PLTP (phospholipid-transfer protein): an emerging role in ‘reverse lipopolysaccharide transport’ and innate immunity
T Gautier, L Lagrost |
Biochemical Society Transactions | 2011 |
Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome
M Vacca, C Degirolamo, R Mariani-Costantini, G Palasciano, A Moschetta |
Wiley Interdisciplinary Reviews: Systems Biology and Medicine | 2011 |
Alzheimer's disease: Cholesterol a menace?
A Mathew, Y Yoshida, T Maekawa, DS Kumar |
Brain Research Bulletin | 2011 |
Pitavastatin Increases ABCA1 Expression by Dual Mechanisms: SREBP2-Driven Transcriptional Activation and PPARα-Dependent Protein Stabilization but Without Activating LXR in Rat Hepatoma McARH7777 Cells
T Maejima, T Sugano, H Yamazaki, Y Yoshinaka, T Doi, S Tanabe, T Nishimaki-Mogami |
Journal of Pharmacological Sciences | 2011 |
Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits
S Honzumi, A Shima, A Hiroshima, T Koieyama, N Terasaka |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2011 |
Characterization of Paralichthys olivaceus peroxisome proliferator-activated receptor-α gene as a master regulator of flounder lipid metabolism
HK Cho, HJ Kong, HY Kim, JH Cheong |
General and Comparative Endocrinology | 2011 |
Nuclear Receptors as Drug Targets for Metabolic Disease
IG Schulman |
Advanced Drug Delivery Reviews | 2010 |
TNF-alpha decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2
FJ Field, K Watt, SN Mathur |
Journal of lipid research | 2010 |
Effects of Liver × receptor agonist treatment on signal transduction pathways in acute lung inflammation
C Crisafulli, E Mazzon, I Paterniti, M Galuppo, P Bramanti, S Cuzzocrea |
Respiratory Research | 2010 |
Coronary heart disease: Significance of liver X receptor α genomics
VP Dave, D Kaul |
World journal of cardiology | 2010 |
LXRα regulates human CETP expression in vitro and in transgenic mice
S Honzumi, A Shima, A Hiroshima, T Koieyama, N Ubukata, N Terasaka |
Atherosclerosis | 2010 |
Differential effects of activation of liver X receptor on plasma lipid homeostasis in wild-type and lipoprotein clearance-deficient mice
D Peng, RA Hiipakka, JT Xie, CA Reardon, GS Getz, S Liao |
Atherosclerosis | 2010 |
Increased expression of RXRα in dementia: an early harbinger for the cholesterol dyshomeostasis?
A Akram, J Schmeidler, P Katsel, PR Hof, V Haroutunian |
Molecular Neurodegeneration | 2010 |
Pioglitazone decreases plasma cholesteryl ester transfer protein mass, associated with a decrease in hepatic triglyceride content, in patients with type 2 diabetes
JT Jonker, Y Wang, W Haan, M Diamant, LJ Rijzewijk, RW van der Meer, HJ Lamb, JT Tamsma, A Roos, JA Romijn, PC Rensen, JW Smit |
Diabetes care | 2010 |
Cholesteryl Ester Transfer Protein Inhibition in Cardiovascular Risk Management: Ongoing Trials will End the Confusion
PJ Kappelle, AV Tol, BH Wolffenbuttel, RP Dullaart |
Cardiovascular Therapeutics | 2010 |
The liver X receptor: Control of cellular lipid homeostasis and beyond
MH Oosterveer, A Grefhorst, AK Groen, F Kuipers |
Progress in Lipid Research | 2010 |
Regulation of cholesterol homeostasis by liver X receptors
YW Hu, L Zheng, Q Wang |
Clinica Chimica Acta | 2010 |
Vitamins & Hormones
KJ Hare, FK Knop |
Vitamins & Hormones | 2010 |
The HDL Handbook
NJ Hime |
The HDL Handbook | 2010 |
TNF-α decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2
FJ Field, K Watt, SN Mathur |
Journal of lipid research | 2010 |
Coronary heart disease: Significance of liver X receptor α genomics
VP Dave |
World journal of cardiology | 2010 |
Minireview: Liver X Receptor β: Emerging Roles in Physiology and Diseases
C Gabbi, M Warner, JÅ Gustafsson |
Molecular Endocrinology | 2009 |
Liver X Receptors as Therapeutic Targets for Managing Cholesterol: Implications for Atherosclerosis and Other Inflammatory Conditions
Y Zhang, JF Chan, CL Cummins |
Clinical Lipidology | 2009 |
The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis
D Masson, XC Jiang, L Lagrost, AR Tall |
Journal of lipid research | 2009 |
Latest Insights Into High-Density Lipoprotein Functions
H Noto |
The Endocrinologist | 2009 |
Molecular cloning of hamster lipid transfer inhibitor protein (apolipoprotein F) and regulation of its expression by hyperlipidemia
L Izem, RE Morton |
Journal of lipid research | 2009 |
Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver
EJ Bighetti, PR Patrício, AC Casquero, JA Berti, HC Oliveira |
Lipids in Health and Disease | 2009 |
The discovery of tertiary-amine LXR agonists with potent cholesterol efflux activity in macrophages
JP Marino, LS Kallander, C Ma, HJ Oh, D Lee, DE Gaitanopoulos, JA Krawiec, DJ Parks, CL Webb, K Ziegler, M Jaye, SK Thompson |
Bioorganic & Medicinal Chemistry Letters | 2009 |
The conjugated linoleic acid isomer trans-9,trans-11 is a dietary occurring agonist of liver X receptor α
J Ecker, G Liebisch, W Patsch, G Schmitz |
Biochemical and Biophysical Research Communications | 2009 |
Serum cholesterol and expression of ApoAI, LXRβ and SREBP2 in vitamin D receptor knock-out mice
JH Wang, T Keisala, T Solakivi, A Minasyan, AV Kalueff, P Tuohimaa |
The Journal of Steroid Biochemistry and Molecular Biology | 2009 |
Liver X receptor modulators: Effects on lipid metabolism and potential use in the treatment of atherosclerosis
C Fiévet, B Staels |
Biochemical Pharmacology | 2009 |
Safety, Pharmacokinetics, and Pharmacodynamics of Single Doses of LXR-623, a Novel Liver X-Receptor Agonist, in Healthy Participants
A Katz, C Udata, E Ott, L Hickey, ME Burczynski, P Burghart, O Vesterqvist, X Meng |
The Journal of Clinical Pharmacology | 2009 |
Bexarotene Induces Dyslipidemia by Increased Very Low-Density Lipoprotein Production and Cholesteryl Ester Transfer Protein-Mediated Reduction of High-Density Lipoprotein
J de Vries-van der Weij, W de Haan, L Hu, M Kuif, HL Oei, JW van der Hoorn, LM Havekes, HM Princen, JA Romijn, JW Smit, PC Rensen |
Endocrinology | 2009 |
Transport−Metabolism Interplay: LXRα-Mediated Induction of Human ABC Transporter ABCC2 (cMOAT/MRP2) in HepG2 Cells
T Adachi, H Nakagawa, Y Hagiya, T Yasuoka, T Ishikawa |
Molecular Pharmaceutics | 2009 |
Liver x receptor: a novel therapeutic target
MB Patel, NA Oza, IS Anand, SS Deshpande, CN Patel |
Indian journal of pharmaceutical sciences | 2008 |
Origins of intestinal ABCA1-mediated HDL-cholesterol
FJ Field, K Watt, SN Mathur |
Journal of lipid research | 2008 |
Fluctuation of lipoprotein metabolism linked with bile acid-activated liver nuclear receptors in Alagille syndrome
H Nagasaka, T Miida, K Hirano, A Ota, K Murayama, T Yorifuji, K Kobayashi, T Takatani, H Tsukahara, SP Hui, M Takayanagi, H Chiba |
Atherosclerosis | 2008 |
Macronutrients and obesity: views, news and reviews
L Madsen, B Liaset, K Kristiansen |
Future Lipidology | 2008 |
Peroxisome Proliferator-Activated Receptor α Agonists Regulate Cholesterol Ester Transfer Protein
TP Beyer, Y Chen, RK Porter, D Lu, RJ Schmidt, NB Mantlo, RJ Konrad, G Cao |
Lipids | 2008 |
Transcriptional regulation of the humanCYP46A1brain-specific expression by Sp transcription factors
I Milagre, MJ Nunes, MJ Gama, RF Silva, JM Pascussi, MC Lechner, E Rodrigues |
Journal of Neurochemistry | 2008 |
CETP activity variation in mice does not affect two major HDL antiatherogenic properties: Macrophage-specific reverse cholesterol transport and LDL antioxidant protection
N Rotllan, L Calpe-Berdiel, A Guillaumet-Adkins, S Süren-Castillo, F Blanco-Vaca, JC Escolà-Gil |
Atherosclerosis | 2008 |
Common variation in theCETPgene and the implications for cardiovascular disease and its treatment: an updated analysis
RP Dullaart, WJ Sluiter |
Pharmacogenomics | 2008 |
Renin–angiotensin–aldosterone responsiveness to low sodium and blood pressure reactivity to angiotensin-II are unrelated to cholesteryl ester transfer protein mass in healthy subjects
JA Krikken, GM Dallinga-Thie, G Navis, RP Dullaart |
Expert Opinion on Therapeutic Targets | 2008 |
Selective partial agonism of liver X receptor alpha is related to differential corepressor recruitment
CA Phelan, JM Weaver, DJ Steger, S Joshi, JT Maslany, JL Collins, WJ Zuercher, TM Willson, M Walker, M Jaye, MA Lazar |
Molecular Endocrinology | 2008 |
Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat
RL Seip, JS Volek, A Windemuth, M Kocherla, ML Fernandez, WJ Kraemer, G Ruaño |
Nutrition & Metabolism | 2008 |
Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice
W Haan, CC van der Hoogt, M Westerterp, M Hoekstra, GM Dallinga-Thie, HM Princen, JA Romijn, JW Jukema, LM Havekes, PC Rensen |
Atherosclerosis | 2008 |
Liver X Receptors (LXR) as Therapeutic Targets in Dyslipidemia
J Bełtowski |
Cardiovascular Therapeutics | 2008 |
Association between liver X receptor α gene polymorphisms and risk of metabolic syndrome in French populations
V Legry, D Cottel, J Ferrières, G Chinetti, T Deroide, B Staels, P Amouyel, A Meirhaeghe |
International Journal of Obesity | 2008 |
Liver X receptor agonist downregulates hepatic apoM expression in vivo and in vitro
X Zhang, Z Zhu, G Luo, L Zheng, P Nilsson-Ehle, N Xu |
Biochemical and Biophysical Research Communications | 2008 |
Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia
A der Graaf, J Rodenburg, MN Vissers, BA Hutten, A Wiegman, MD Trip, ES Stroes, FA Wijburg, JD Otvos, JJ Kastelein |
The Journal of Pediatrics | 2008 |
Origins of intestinal ABCA1-mediated HDL-cholesterol
FJ Field, K Watt, SN Mathur |
Journal of lipid research | 2008 |
The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis
D Masson, XC Jiang, L Lagrost, AR Tall |
Journal of lipid research | 2008 |
Molecular cloning of hamster lipid transfer inhibitor protein (apolipoprotein F) and regulation of its expression by hyperlipidemia
L Izem, RE Morton |
Journal of lipid research | 2008 |
Atherosclerosis and Oxidant Stress
JL Holtzman |
2008 | |
GW3965, a synthetic liver X receptor (LXR) agonist, reduces angiotensin II-mediated pressor responses in Sprague-Dawley rats
CE Leik, NL Carson, JK Hennan, MD Basso, QY Liu, DL Crandall, P Nambi |
British Journal of Pharmacology | 2007 |
Comprehensive Medicinal Chemistry II
E Littler, XX Zhou |
Comprehensive Medicinal Chemistry II | 2007 |
A Key Role for Orphan Nuclear Receptor Liver Receptor Homologue-1 in Activation of Fatty Acid Synthase Promoter by Liver X Receptor
KE Matsukuma, L Wang, MK Bennett, TF Osborne |
The Journal of biological chemistry | 2007 |
Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression
CC van der Hoogt, W Haan, M Westerterp, M Hoekstra, GM Dallinga-Thie, JA Romijn, HM Princen, JW Jukema, LM Havekes, PC Rensen |
Journal of lipid research | 2007 |
High‐Density Lipoproteins: From Basic Biology to Clinical Aspects
CJ Fielding |
2007 | |
Liver X receptors as integrators of metabolic and inflammatory signaling
N Zelcer, P Tontonoz |
Journal of Clinical Investigation | 2006 |
International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor α, Farnesoid X Receptor β, Liver X Receptor α, Liver X Receptor β, and Vitamin D Receptor
DD Moore, S Kato, W Xie, DJ Mangelsdorf, DR Schmidt, R Xiao, SA Kliewer |
Pharmacological reviews | 2006 |
A role for CETP TaqIB polymorphism in determining susceptibility to atrial fibrillation: a nested case control study
FW Asselbergs, JH Moore, MP van Berg, EB Rimm, RA de Boer, RP Dullaart, G Navis, WH van Gilst |
BMC Medical Genetics | 2006 |
REGULATION OF HEPATIC CHOLESTEROL METABOLISM IN CETP+/?/LDLr+/?MICE BY CHOLESTEROL FEEDING AND BY DRUGS (CHOLESTYRAMINE AND LOVASTATIN) THAT LOWER PLASMA CHOLESTEROL
LM Harada, AJ Carrilho, HC Oliveira, ER Nakandakare, EC Quintão |
Clinical and Experimental Pharmacology and Physiology | 2006 |
Plasma lipid transfer proteins
XC Jiang, HW Zhou |
Current Opinion in Lipidology | 2006 |
LXRS AND FXR: The Yin and Yang of Cholesterol and Fat Metabolism
NY Kalaany, DJ Mangelsdorf |
Annual Review of Physiology | 2006 |
Nuclear receptors as drug targets in metabolic diseases: new approaches to therapy
JF Tobin, LP Freedman |
Trends in Endocrinology & Metabolism | 2006 |
Liver X receptors: new drug targets to treat Type 2 diabetes?
KR Steffensen, JÅ Gustafsson |
Future Lipidology | 2006 |
SYNERGISTIC EFFECT OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-?? AND LIVER X RECEPTOR-?? IN THE REGULATION OF INFLAMMATION IN MACROPHAGES
G Piraino, JA Cook, M O'Connor, PW Hake, TJ Burroughs, D Teti, B Zingarelli |
Shock | 2006 |
¿Existen aún nuevas dianas terapéuticas en la arteriosclerosis? LXR y FXR
J Martínez-González, L Badimón |
Clínica e Investigación en Arteriosclerosis | 2006 |
Correction of Apolipoprotein A-I-mediated Lipid Efflux and High Density Lipoprotein Particle Formation in Human Niemann-Pick Type C Disease Fibroblasts
E Boadu, HY Choi, DW Lee, EI Waddington, T Chan, B Asztalos, JE Vance, A Chan, G Castro, GA Francis |
The Journal of biological chemistry | 2006 |
Phosphorylation of the Hinge Domain of the Nuclear Hormone Receptor LRH-1 Stimulates Transactivation
YK Lee, YH Choi, S Chua, YJ Park, DD Moore |
The Journal of biological chemistry | 2006 |
A 15-ketosterol is a liver X receptor ligand that suppresses sterol-responsive element binding protein-2 activity
RJ Schmidt, JV Ficorilli, Y Zhang, KS Bramlett, TP Beyer, K Borchert, MS Dowless, KA Houck, TP Burris, PI Eacho, G Liang, L Guo, WK Wilson, LF Michael, G Cao |
Journal of lipid research | 2006 |
Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase
KE Matsukuma, MK Bennett, J Huang, L Wang, G Gil, TF Osborne |
Journal of lipid research | 2006 |
Reduced Fat Mass in Rats Fed a High Oleic Acid–Rich Safflower Oil Diet Is Associated with Changes in Expression of Hepatic PPARα and Adipose SREBP-1c–Regulated Genes1,2
SC Hsu, C Huang |
The Journal of nutrition | 2006 |
Transcriptional regulatory networks in lipid metabolism control ABCA1 expression
G Schmitz, T Langmann |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2005 |
Hepatic Peroxisomal Fatty Acid β-Oxidation Is Regulated by Liver X Receptor α
T Hu, P Foxworthy, A Siesky, JV Ficorilli, H Gao, S Li, M Christe, T Ryan, G Cao, P Eacho, MD Michael, LF Michael |
Endocrinology | 2005 |
LXR is crucial in lipid metabolism
SM Ulven, KT Dalen, JÅ Gustafsson, HI Nebb |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 2005 |
Retinoid X Receptor Heterodimers in the Metabolic Syndrome
AI Shulman, DJ Mangelsdorf |
New England Journal of Medicine | 2005 |
Skin Barrier: Epidermal Liposensors
M Schmuth |
Skin Barrier | 2005 |
LXR: A nuclear receptor target for cardiovascular disease?
MN Bradley, P Tontonoz |
Drug Discovery Today: Therapeutic Strategies | 2005 |
Synthetic LXR agonists increase LDL in CETP species
PH Groot, NJ Pearce, JW Yates, C Stocker, C Sauermelch, CP Doe, RN Willette, A Olzinski, T Peters, D d'Epagnier, KO Morasco, JA Krawiec, CL Webb, K Aravindhan, B Jucker, M Burgert, C Ma, JP Marino, JL Collins, CH Macphee, SK Thompson, M Jaye |
Journal of lipid research | 2005 |
Identification and characterization of two alternatively spliced transcript variants of human liver X receptor alpha
M Chen, S Beaven, P Tontonoz |
Journal of lipid research | 2005 |
Lack of stimulation of cholesteryl ester transfer protein by cholesterol in the presence of a high-fat diet
SK Cheema, A Agarwal-Mawal, CM Murray, S Tucker |
Journal of lipid research | 2005 |
Regulation of the Aldo-Keto Reductase Gene akr1b7 by the Nuclear Oxysterol Receptor LXRα (Liver X Receptor-α) in the Mouse Intestine: Putative Role of LXRs in Lipid Detoxification Processes
DH Volle, JJ Repa, A Mazur, CL Cummins, P Val, J Henry-Berger, F Caira, G Veyssiere, DJ Mangelsdorf, JM Lobaccaro |
Molecular Endocrinology | 2004 |
Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia
WL Goff, M Guerin, MJ Chapman |
Pharmacology & Therapeutics | 2004 |
A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes
Y Liang, S Lin, TP Beyer, Y Zhang, X Wu, KR Bales, RB DeMattos, PC May, SD Li, XC Jiang, PI Eacho, G Cao, SM Paul |
Journal of Neurochemistry | 2004 |
Molecular regulation of SREBP function: the Insig-SCAP connection and isoform-specific modulation of lipid synthesis
R McPherson, A Gauthier |
Biochemistry and Cell Biology | 2004 |
Expression of the liver X receptor ? and ? in embryonic and adult mice
JS Annicotte, K Schoonjans, J Auwerx |
The Anatomical Record | 2004 |
Liver X receptor agonists as a treatment for atherosclerosis
DJ Bennett, AJ Cooke, AS Edwards, E Moir, PC Ray |
Expert Opinion on Therapeutic Patents | 2004 |
Cholesteryl ester transfer protein promoter single-nucleotide polymorphisms in Sp1-binding sites affect transcription and are associated with high-density lipoprotein cholesterol
JF Thompson, DB Lloyd, ME Lira, PM Milos |
Clinical Genetics | 2004 |
Les oxystérols : métabolisme, rôles biologiques et pathologies associées
M Souidi, S Dubrac, M Parquet, DH Volle, JM Lobaccaro, D Mathé, O Combes, P Scanff, C Lutton, J Aigueperse |
Gastroentérologie Clinique et Biologique | 2004 |
Oxysterols and oxysterol binding proteins: role in lipid metabolism and atherosclerosis
VM Olkkonen, M Lehto |
Annals of Medicine | 2004 |
Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice
T GAUTIER, D MASSON, MC JONG, JP BARROS, L DUVERNEUIL, NL GUERN, V DECKERT, L DUMONT, A BATAILLE, Z ZAK, XC JIANG, LM HAVEKES, L LAGROST |
Biochemical Journal | 2004 |
Coadministration of a Liver X Receptor Agonist and a Peroxisome Proliferator Activator Receptor-α Agonist in Mice: Effects of Nuclear Receptor Interplay on High-Density Lipoprotein and Triglyceride Metabolism in Vivo
TP Beyer, RJ Schmidt, P Foxworthy, Y Zhang, J Dai, WR Bensch, RF Kauffman, H Gao, TP Ryan, XC Jiang, SK Karathanasis, PI Eacho, G Cao |
The Journal of pharmacology and experimental therapeutics | 2004 |
The Nuclear Oxysterol Receptor LXRα Is Expressed in the Normal Human Breast and in Breast Cancer
DM Vigushin, Y Dong, L Inman, N Peyvandi, JP Alao, C Sun, S Ali, EJ Niesor, CL Bentzen, RC Coombes |
Medical Oncology | 2004 |
Potentiation of liver X receptor transcriptional activity by peroxisome-proliferator-activated receptor gamma co-activator 1 alpha
H Oberkofler, E Schraml, F Krempler, W Patsch |
Biochemical Journal | 2003 |
Liver X receptor signaling pathways in cardiovascular disease
P Tontonoz, DJ Mangelsdorf |
Molecular Endocrinology | 2003 |
An evolutionary approach for identifying potential transcription factor binding sites: the renin gene as an example
KR Steffensen, JA Gustafsson |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2003 |
An evolutionary approach for identifying potential transcription factor binding sites: the renin gene as an example
KR Steffensen, JA Gustafsson |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2003 |
HDL: The Metabolism, Function, and Therapeutic Importance
M Wang, MR Briggs |
Chemical Reviews | 2003 |
Oxysterol and 9-cis-retinoic acid stimulate the group IIA secretory phospholipase A2 gene in rat smooth-muscle cells
V Antonio, B Janvier, A Brouillet, M Andreani, M Raymondjean |
Biochemical Journal | 2003 |
NUCLEARRECEPTORS AND THECONTROL OFMETABOLISM
GA Francis, E Fayard, F Picard, J Auwerx |
Annual Review of Physiology | 2003 |
Cholesterol-receptor-mediated genomics in health and disease
D Kaul |
Trends in Molecular Medicine | 2003 |
Atheroprotective Effects of High-Density Lipoproteins
G Assmann, JR Nofer |
Annual Review of Medicine | 2003 |
Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue
BA Laffitte, LC Chao, J Li, R Walczak, S Hummasti, SB Joseph, A Castrillo, DC Wilpitz, DJ Mangelsdorf, JL Collins, E Saez, P Tontonoz |
Proceedings of the National Academy of Sciences | 2003 |
Effects of dietary 27-hydroxycholesterol on cholesterol metabolism and bile acid biosynthesis in the hamster
M Souidi, S Dubrac, M Parquet, F Milliat, J Férézou, C Sérougne, C Loison, M Riottot, N Boudem, T Bécue, C Lutton |
Canadian Journal of Physiology and Pharmacology | 2003 |
Expression, regulation, and activity of ABCA1 in human cell lines
M Denis, R Bissonnette, B Haidar, L Krimbou, M Bouvier, J Genest |
Molecular Genetics and Metabolism | 2003 |
Temporal gene expression changes during adipogenesis in human mesenchymal stem cells
T Nakamura, S Shiojima, Y Hirai, T Iwama, N Tsuruzoe, A Hirasawa, S Katsuma, G Tsujimoto |
Biochemical and Biophysical Research Communications | 2003 |
Syntheses of oxysterol receptors’(LXRs) ligands
X Zhou, H Zhen, W Zhou |
Chinese Science Bulletin | 2003 |
Molecular determinants of LXRα agonism
M Wang, J Thomas, TP Burris, J Schkeryantz, LF Michael |
Journal of Molecular Graphics and Modelling | 2003 |
N UCLEAR R ECEPTORS AND THE C ONTROL OF M ETABOLISM
GA Francis, E Fayard, F Picard, J Auwerx |
Annual Review of Physiology | 2003 |
Pharmacological evidence for a role of liver X receptors in atheroprotection
PT Kovanen, MO Pentikäinen |
FEBS Letters | 2003 |
An evolutionary approach for identifying potential transcription factor binding sites: the renin gene as an example
KR Steffensen, JA Gustafsson |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2003 |
Lipids and Atherosclerosis Annual 2003
I Schulman, R Heyman |
Lipids and Atherosclerosis Annual 2003 | 2003 |
Los receptores nucleares como nuevas dianas terapéuticas para un manejo integral de las dislipemias
A Rigotti |
Clínica e Investigación en Arteriosclerosis | 2003 |
Enlargement of High Density Lipoprotein in Mice via Liver X Receptor Activation Requires Apolipoprotein E and Is Abolished by Cholesteryl Ester Transfer Protein Expression
XC Jiang, TP Beyer, Z Li, J Liu, W Quan, RJ Schmidt, Y Zhang, WR Bensch, PI Eacho, G Cao |
The Journal of biological chemistry | 2003 |
Expression of the Insulin-responsive Glucose Transporter GLUT4 in Adipocytes Is Dependent on Liver X Receptor α
KT Dalen, SM Ulven, K Bamberg, JÅ Gustafsson, HI Nebb |
The Journal of biological chemistry | 2003 |
Hypertriglyceridemia in Lecithin-cholesterol Acyltransferase-deficient Mice Is Associated with Hepatic Overproduction of Triglycerides, Increased Lipogenesis, and Improved Glucose Tolerance
DS Ng, C Xie, GF Maguire, X Zhu, F Ugwu, E Lam, PW Connelly |
The Journal of biological chemistry | 2003 |
Regulation of ABCA1 expression and cholesterol efflux during adipose differentiation of 3T3-L1 cells
SL Lay, C Robichon, XL Liepvre, G Dagher, P Ferre, I Dugail |
Journal of lipid research | 2003 |
Regulation of human CETP gene expression: role of SP1 and SP3 transcription factors at promoter sites −690, −629, and −37
WL Goff, M Guerin, L Petit, MJ Chapman, J Thillet |
Journal of lipid research | 2003 |
Cholesteryl ester transfer protein modulates the effect of liver X receptor agonists on cholesterol transport and excretion in the mouse
D Masson, B Staels, T Gautier, C Desrumaux, A Athias, NL Guern, M Schneider, Z Zak, L Dumont, V Deckert, A Tall, XC Jiang, L Lagrost |
Journal of lipid research | 2003 |
Cholesteryl ester transfer protein expression is down-regulated in hyperinsulinemic transgenic mice
JA Berti, AC Casquero, PR Patrício, EJ Bighetti, EM Carneiro, AC Boschero, HC Oliveira |
Journal of lipid research | 2003 |
A CYP7A promoter binding factor site and Alu repeat in the distal promoter region are implicated in regulation of human CETP gene expression
WL Goff, M Guerin, MJ Chapman, J Thillet |
Journal of lipid research | 2003 |
Activating Signal Cointegrator 2 Required for Liver Lipid Metabolism Mediated by Liver X Receptors in Mice
SW Kim, K Park, E Kwak, E Choi, S Lee, J Ham, H Kang, JM Kim, SY Hwang, YY Kong, K Lee, JW Lee |
Molecular and cellular biology | 2003 |
Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis
LJ Millatt, V Bocher, JC Fruchart, B Staels |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2003 |
Frontiers in Cardiovascular Health
NS Dhalla, A Chockalingam, HI Berkowitz, PK Singal |
2003 | |
A Natural Product Ligand of the Oxysterol Receptor, Liver X Receptor
KS Bramlett, KA Houck, KM Borchert, MS Dowless, P Kulanthaivel, Y Zhang, TP Beyer, R Schmidt, JS Thomas, LF Michael, R Barr, C Montrose, PI Eacho, G Cao, TP Burris |
The Journal of pharmacology and experimental therapeutics | 2003 |
Liver X Receptors Interact with Corepressors to Regulate Gene Expression
X Hu, S Li, J Wu, C Xia, DS Lala |
Molecular Endocrinology | 2003 |
A Novel Liver X Receptor Agonist Establishes Species Differences in the Regulation of Cholesterol 7α-Hydroxylase (CYP7a)
JG Menke, KL Macnaul, NS Hayes, J Baffic, YS Chao, A Elbrecht, LJ Kelly, MH Lam, A Schmidt, S Sahoo, J Wang, SD Wright, P Xin, G Zhou, DE Moller, CP Sparrow |
Endocrinology | 2002 |
Bile Acid Regulation of Gene Expression: Roles of Nuclear Hormone Receptors
JY Chiang |
Endocrine reviews | 2002 |
Synthetic LXR ligand inhibits the development of atherosclerosis in mice
SB Joseph, E McKilligin, L Pei, MA Watson, AR Collins, BA Laffitte, M Chen, G Noh, J Goodman, GN Hagger, J Tran, TK Tippin, X Wang, AJ Lusis, WA Hsueh, RE Law, JL Collins, TM Willson, P Tontonoz |
Proceedings of the National Academy of Sciences | 2002 |
Wiley Encyclopedia of Molecular Medicine
WT Morgan |
Wiley Encyclopedia of Molecular Medicine | 2002 |
Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1
JF Oram |
Trends in Molecular Medicine | 2002 |
Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism
SE Ross, RL Erickson, I Gerin, PM DeRose, L Bajnok, KA Longo, DE Misek, R Kuick, SM Hanash, KB Atkins, SM Andresen, HI Nebb, L Madsen, K Kristiansen, OA MacDougald |
Molecular and cellular biology | 2002 |
Oxysterol-activated LXR/RXR induces SR-BI-promoter activity in hepatoma cells and preadipocytes
L Malerød, LK Juvet, A Hanssen-Bauer, W Eskild, T Berg |
Biochemical and Biophysical Research Communications | 2002 |
Liver X receptor and retinoic X receptor mediated ABCA1 regulation and cholesterol efflux in macrophage cells—messenger RNA measured by branched DNA technology
Y Zhang, TP Beyer, KS Bramlett, S Yao, TP Burris, RJ Schmidt, PI Eacho, G Cao |
Molecular Genetics and Metabolism | 2002 |
Genetic disorders associated with ATP binding cassette cholesterol transporters
TP Burris, PI Eacho, G Cao |
Molecular Genetics and Metabolism | 2002 |
Oxysterols in human circulation: which role do they have?
I Björkhem, S Meaney, U Diczfalusy |
Current Opinion in Lipidology | 2002 |
Genetics and molecular biology: apolipoprotein E - from plasma lipids to plaque stability
S Lorkowski, P Cullen |
Current Opinion in Lipidology | 2002 |
Oxysterol Stimulation of Epidermal Differentiation is Mediated by Liver X Receptor-beta in Murine Epidermis
LG Komuves, M Schmuth, AJ Fowler, PM Elias, K Hanley, MQ Man, AH Moser, JM Lobaccaro, ML Williams, DJ Mangelsdorf, KR Feingold |
Journal of Investigative Dermatology | 2002 |
A Short and Highly Stereoselective Synthesis of Cerebrosterol
DH Zhang, XD Zhou, WS Zhou |
Chinese Journal of Chemistry | 2002 |
Nuclear receptor regulation of hepatic function
SJ Karpen |
Journal of Hepatology | 2002 |
The liver X receptor gene team: Potential new players in atherosclerosis
JJ Repa, DJ Mangelsdorf |
Nature Medicine | 2002 |
Novel roles of liver X receptors exposed by gene expression profiling in liver and adipose tissue
TM Stulnig, KR Steffensen, H Gao, M Reimers, K Dahlman-Wright, GU Schuster, JA Gustafsson |
Molecular pharmacology | 2002 |
Liver X Receptors Downregulate 11 -Hydroxysteroid Dehydrogenase Type 1 Expression and Activity
TM Stulnig, U Oppermann, KR Steffensen, GU Schuster, JA Gustafsson |
Diabetes | 2002 |
Phospholipid Transfer Protein Is Regulated by Liver X Receptors in Vivo
G Cao, TP Beyer, XP Yang, RJ Schmidt, Y Zhang, WR Bensch, RF Kauffman, H Gao, TP Ryan, Y Liang, PI Eacho, XC Jiang |
The Journal of biological chemistry | 2002 |
Antidiabetic Action of a Liver X Receptor Agonist Mediated By Inhibition of Hepatic Gluconeogenesis
G Cao, Y Liang, CL Broderick, BA Oldham, TP Beyer, RJ Schmidt, Y Zhang, KR Stayrook, C Suen, KA Otto, AR Miller, J Dai, P Foxworthy, H Gao, TP Ryan, XC Jiang, TP Burris, PI Eacho, GJ Etgen |
The Journal of biological chemistry | 2002 |
A Chemical Switch Regulates Fibrate Specificity for Peroxisome Proliferator-activated Receptor α (PPARα) Versus Liver X Receptor
J Thomas, KS Bramlett, C Montrose, P Foxworthy, PI Eacho, D McCann, G Cao, A Kiefer, J McCowan, K Yu, T Grese, WW Chin, TP Burris, LF Michael |
The Journal of biological chemistry | 2002 |
LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells
S Murthy, E Born, SN Mathur, FJ Field |
Journal of lipid research | 2002 |
The Small Heterodimer Partner Interacts with the Liver X Receptor α and Represses Its Transcriptional Activity
C Brendel, K Schoonjans, OA Botrugno, E Treuter, J Auwerx |
Molecular Endocrinology | 2002 |
Regulation of Cholesterol Homeostasis by the Liver X Receptors in the Central Nervous System
KD Whitney, MA Watson, JL Collins, WG Benson, TM Stone, MJ Numerick, TK Tippin, JG Wilson, DA Winegar, SA Kliewer |
Molecular Endocrinology | 2002 |
BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis
PA Edwards, HR Kast, AM Anisfeld |
Journal of lipid research | 2002 |
Xol INXS: role of the liver X and the farnesol X receptors
E Fayard, K Schoonjans, J Auwerx |
Current Opinion in Lipidology | 2001 |
Novel approaches to treating cardiovascular disease: lessons from Tangier disease
JF Oram |
Expert Opinion on Investigational Drugs | 2001 |
Expression of the ATP-Binding Cassette Transporter Gene ABCG1 (ABC8) in Tangier Disease
S Lorkowski, M Kratz, C Wenner, R Schmidt, B Weitkamp, M Fobker, J Reinhardt, J Rauterberg, EA Galinski, P Cullen |
Biochemical and Biophysical Research Communications | 2001 |
Hypolipidemic effects of selective liver X receptor alpha agonists
C Song, S Liao |
Steroids | 2001 |
Auto-oxidized cholesterol sulfates are antagonistic ligands of liver X receptors: implications for the development and treatment of atherosclerosis
C Song, RA Hiipakka, S Liao |
Steroids | 2001 |
Regulation of cholesterol 7α-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRα)
JY Chiang, R Kimmel, D Stroup |
Gene | 2001 |
A new highly stereoselective synthesis of cerebrosterol, an agonist of the nuclear receptor LXRs
XD Zhou, WS Zhou |
Tetrahedron | 2001 |
Glucose Regulates the Transcription of Human Genes Relevant to HDL Metabolism: Responsive Elements for Peroxisome Proliferator-Activated Receptor Are Involved in the Regulation of Phospholipid Transfer Protein
AY Tu, JJ Albers |
Diabetes | 2001 |
Characterization of the Human ABCG1 Gene: LIVER X RECEPTOR ACTIVATES AN INTERNAL PROMOTER THAT PRODUCES A NOVEL TRANSCRIPT ENCODING AN ALTERNATIVE FORM OF THE PROTEIN
MA Kennedy, A Venkateswaran, PT Tarr, I Xenarios, J Kudoh, N Shimizu, PA Edwards |
The Journal of biological chemistry | 2001 |
27-Hydroxycholesterol Is an Endogenous Ligand for Liver X Receptor in Cholesterol-loaded Cells
X Fu, JG Menke, Y Chen, G Zhou, KL MacNaul, SD Wright, CP Sparrow, EG Lund |
The Journal of biological chemistry | 2001 |
The Orphan Nuclear Receptor LRH-1 Potentiates the Sterol-mediated Induction of the Human CETP Gene by Liver X Receptor
Y Luo, C Liang, AR Tall |
The Journal of biological chemistry | 2001 |
Orphan Nuclear Receptors as eLiXiRs and FiXeRs of Sterol Metabolism
TT Lu, JJ Repa, DJ Mangelsdorf |
The Journal of biological chemistry | 2001 |
Polyunsaturated Fatty Acids Suppress Sterol Regulatory Element-binding Protein 1c Promoter Activity by Inhibition of Liver X Receptor (LXR) Binding to LXR Response Elements
T Yoshikawa, H Shimano, N Yahagi, T Ide, M Amemiya-Kudo, T Matsuzaka, M Nakakuki, S Tomita, H Okazaki, Y Tamura, Y Iizuka, K Ohashi, A Takahashi, H Sone, J Osuga, T Gotoda, S Ishibashi, N Yamada |
The Journal of biological chemistry | 2001 |
Regulation of Lipoprotein Lipase by the Oxysterol Receptors, LXRα and LXRβ
Y Zhang, JJ Repa, K Gauthier, DJ Mangelsdorf |
The Journal of biological chemistry | 2001 |
Cholesteryl Ester Transfer Protein Biosynthesis and Cellular Cholesterol Homeostasis Are Tightly Interconnected
L Izem, RE Morton |
The Journal of biological chemistry | 2001 |
Identification of Liver X Receptor-Retinoid X Receptor as an Activator of the Sterol Regulatory Element-Binding Protein 1c Gene Promoter
T Yoshikawa, H Shimano, M Amemiya-Kudo, N Yahagi, AH Hasty, T Matsuzaka, H Okazaki, Y Tamura, Y Iizuka, K Ohashi, JI Osuga, K Harada, T Gotoda, S Kimura, S Ishibashi, N Yamada |
Molecular and cellular biology | 2001 |
High Density Lipoproteins and Arteriosclerosis: Role of Cholesterol Efflux and Reverse Cholesterol Transport
A von Eckardstein, JR Nofer, G Assmann |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
Point Mutation (−69 G→A) in the Promoter Region of Cholesteryl Ester Transfer Protein Gene in Japanese Hyperalphalipoproteinemic Subjects
M Nagano, S Yamashita, K Hirano, T Kujiraoka, M Ito, Y Sagehashi, H Hattori, N Nakajima, T Maruyama, N Sakai, T Egashira, Y Matsuzawa |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance
JC Escolà-Gil, J Julve, À Marzal-Casacuberta, J Ordóñez-Llanos, F González-Sastre, F Blanco-Vaca |
Journal of lipid research | 2001 |
The OSBP-related protein family in humans
M Lehto, S Laitinen, G Chinetti, M Johansson, C Ehnholm, B Staels, E Ikonen, VM Olkkonen |
Journal of lipid research | 2001 |
Molecular link between cholesterol, cytokines and atherosclerosis
D Kaul |
Molecular and Cellular Biochemistry | 2001 |
Tangier disease and ABCA1
J Oram |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2000 |
Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein
S Yamashita |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2000 |
Cholesteryl ester transfer protein and atherosclerosis
A Inazu, J Koizumi, H Mabuchi |
Current Opinion in Lipidology | 2000 |
Nuclear receptors in metabolic diseases
R Mukherjee, JA Saye, PR Young |
Expert Opinion on Therapeutic Targets | 2000 |
Pros and cons of inhibiting cholesteryl ester transfer protein
K Hirano, S Yamashita, Y Matsuzawa |
Current Opinion in Lipidology | 2000 |
Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?
A Eckardstein, G Assmann |
Current Opinion in Lipidology | 2000 |
Role of LXRs in control of lipogenesis
JR Schultz, H Tu, A Luk, JJ Repa, JC Medina, L Li, S Schwendner, S Wang, M Thoolen, DJ Mangelsdorf, KD Lustig, B Shan |
Genes & development | 2000 |
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta
JJ Repa, G Liang, J Ou, Y Bashmakov, JM Lobaccaro, I Shimomura, B Shan, MS Brown, JL Goldstein, DJ Mangelsdorf |
Genes & development | 2000 |
Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha
A Venkateswaran, BA Laffitte, SB Joseph, PA Mak, DC Wilpitz, PA Edwards, P Tontonoz |
Proceedings of the National Academy of Sciences | 2000 |
ABC1 Gene Expression and ApoA-I-Mediated Cholesterol Efflux Are Regulated by LXR
K Schwartz, RM Lawn, DP Wade |
Biochemical and Biophysical Research Communications | 2000 |
The important role of residue F268 in ligand binding by LXRβ
F Urban, G Cavazos, J Dunbar, B Tan, P Escher, S Tafuri, M Wang |
FEBS Letters | 2000 |
Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor
JJ Repa, SD Turley, JA Lobaccaro, J Medina, L Li, K Lustig, B Shan, RA Heyman, JM Dietschy, DJ Mangelsdorf |
The Journal of biological chemistry | 2000 |
1999 George Lyman Duff memorial lecture: lipid transfer proteins, HDL metabolism, and atherogenesis
AR Tall, X Jiang, Y Luo, D Silver |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Thyroid Hormone Stimulates Acetyl-CoA Carboxylase-α Transcription in Hepatocytes by Modulating the Composition of Nuclear Receptor Complexes Bound to a Thyroid Hormone Response Element
Y Zhang, L Yin, FB Hillgartner |
The Journal of biological chemistry | 2000 |
‘Orphans’ meet cholesterol
AR Tall, P Costet, Y Luo |
Nature Medicine | 2000 |
A, B, C…γ!
AR Tall, CW Schindler |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Cholestenoic Acid Is a Naturally Occurring Ligand for Liver X Receptor α**This work was supported by NIH grants
C Song, S Liao |
Endocrinology | 2000 |
Advances in Molecular and Cellular Endocrinology
MR Pollak, EM Brown |
Advances in Molecular and Cellular Endocrinology | 1997 |
Identification of negative and positive regulatory elements in the human renin gene
LM Anderson, SE Choe, RY Yukhananov, RL Hopfner, GM Church, RE Pratt, VJ Dzau |
The Journal of biological chemistry | 1989 |